Ellis Neufeld is Appointed as New Associate Editor of Blood
Blood Journals Portfolio shared a post on LinkedIn:
”We’re pleased to welcome another new Associate Editor to Blood!
Dr. Ellis Neufeld trained as a pediatric ‘classical’ hematologist and geneticist and is an experienced clinical investigator in blood disorders.
He has led observational and interventional studies in thalassemia, iron chelation, ITP, and hemophilia.
He is a founding leader of the ICON ITP consortium.
For NHLBI he has served on steering committees for multicenter clinical trial groups in Thalassemia (TCRN) and Transfusion Medicine/Hemostasis (TMHCRN); and he presently serves on the NHLBI Board of External Experts.
In ‘bedside to bench’ translational studies, he elucidated the role of the SLC19A2 transporter gene in Thiamine-Responsive Anemia, discovered a rare GATA-1 mutation in X-linked thalassemia, and studied the dominant sickling mutation, Hemoglobin Jamaica Plain.
After 32 years at Boston Children’s Hospital, he moved to St. Jude Children’s Research Hospital in 2017 to serve as Chief Medical Officer.
He is still currently there as Executive Vice President, Clinical Director, Physician-in-Chief, and John and Lorine Thrasher Endowed Chair in Pediatric Medicine.
His early research training included a PhD on platelet arachidonate metabolism, and a postdoc studying gp91-phox expression in myeloid cells.
The Blood Editorial Team is lucky to have Dr. Neufeld on board.
He started this position January 1 and we couldn’t be more ecstatic.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM